The logo of Gilead Sciences Inc is pictured during a news conference in New Delhi September 15, 2014. REUTERS/Anindito Mukherjee/File Photo (Reuters) – A federal judge in Delaware has overturned a jury’s verdict requiring Gilead Sciences Inc to pay a record $2... More »
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, ope... More »
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland, January 25, 2017. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Switzerland’s Novartis AG (NOVN.S) is preparing to auction its U.S. generic pill business, loo... More »
FILE PHOTO: – A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences In... More »
FILE PHOTO: – A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences In... More »
A worker collects cuttings from a marijuana plant at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. REUTERS/Chris Wattie TORONTO (Reuters) – Canopy Growth Corp, one of the world’s biggest medical marijuana producers, ... More »
Adults who get a flu shot are 36 percent less likely to get the disease, while for children the figure was an unexpectedly high 59 percent, U.S. health officials said on Thursday, predicting that the current "intense" season could continue for weeks. More »
FILE PHOTO – A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo (Reuters) – U.S. regulators have proposed lowering the bar for clinical trial success for experimental ... More »
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Swiss drugmaker Roche Holding AG (ROG.S) said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health ... More »
An undated picture shows a magnification of a lab-grown fully matured human egg ready for fertilization. Doctor David Albertini/University of Edinburgh/Handout via REUTERS LONDON, (Reuters) – Scientists have succeeded for the first time in growing human eggs i... More »
Emergency room nurse Christine Bauer treats Joshua Lagade of Vista, California, for the flu as his girlfriend Mayra Mora looks on in the emergency room at Palomar Medical Center in Escondido, California, U.S., January 18, 2018. REUTERS/Mike Blake (Reuters) – T... More »
TOKYO/MELBOURNE (Reuters) – Researchers in Japan and Australia say they have made important progress in developing a blood test that could in future help doctors detect who might go on to get Alzheimer’s disease. In a study published in the journal Nature, the... More »
Dr. Rolando Enrique Domingo (R), Undersecretary of the Department of Health (DOH), with Dr. Gerardo Legaspi, Director of the Philippine General Hospital (PGH), answer questions during a news conference at the DOH headquarter in metro Manila, Philippines Februa... More »
FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, appears in an undated photograph provided by the U.S. Attorney’s Office for the Southern District of Alabama. U.S. Attorney’s Office for the Southern District of Alabama/Hando... More »
NEW YORK (Reuters) – Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co. In a complaint filed in the... More »
FILE PHOTO: A trader works by the post that trades AbbVie on the floor of the New York Stock Exchange March 5, 2015. REUTERS/Brendan McDermid (Reuters) – A federal jury in Chicago on Friday found AbbVie Inc (ABBV.N) not liable in a lawsuit by an Arizona man wh... More »
Logo of Swiss drugmaker Roche is seen beside the entrance of its research unit Roche Glycart AG in Schlieren, Switzerland December 18, 2017. REUTERS/Arnd Wiegmann (Reuters) – A costly new Roche Holding AG drug to treat the bleeding disorder hemophilia A could ... More »
(Reuters) – The U.S. Food and Drug Administration on Thursday approved a radioactive drug to treat the ultra-rare type of digestive tract cancer that killed Steve Jobs in 2011. The approval for Advanced Accelerator Applications SA’s Lutathera comes just days a... More »
(Reuters) – Canadian generic drug maker Apotex Inc’s Chief Executive Jeremy Desai has resigned, effective immediately, the company said on Friday. Desai resigned to pursue other opportunities, Apotex said in an emailed statement without elaborating. Company ve... More »
A homeless person is flu vaccinated as she registered to enter as transitional camp area for homeless people at the city’s works yard in San Diego, California, U.S., October 9, 2017. REUTERS/Mike Blake CHICAGO (Reuters) – Flu continues to be widespread across ... More »
The chairman of Swiss pharmaceutical company Roche, Christoph Franz speaks to media after the annual general meeting in Basel March 4, 2014. REUTERS/Ruben Sprich ZURICH (Reuters) – Fears U.S. President Donald Trump could damage the drugs industry have not been... More »
A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) – AstraZeneca said an inhaler for chronic obstructive pulmonary disease (COPD) delivered improved lung function in a late stage trial t... More »
The view of what a surgeon would see is shown with a three-dimensional image on a da Vinci Xi Surgical System made by Intuitive Surgical during a demonstrated of the surgery robot at the Palomar Medical Center in Escondido, California December 3, 2014. REUTERS... More »
FILE PHOTO: Signs are placed around a neighborhood as county vector control hand-spray a for adult Aedes mosquitoes after a travel-related case of Zika was confirmed in this the area of San Diego, California, U.S. September 12, 2016. REUTERS/Mike Blake CHICAGO... More »
Zhong Zhong and Hua Hua, two cloned long tailed macaque monkeys are seen at the Non-Primate facility at the Chinese Academy of Sciences in Shanghai, China January 10, 2018. Picture taken January 10, 2018. Qiang Sun and Mu-ming Poo, Chinese Academy of Sciences ... More »
FILE PHOTO: A pharmacist holds prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. at a local pharmacy, in Provo, Utah, U.S. on April 25, 2017. REUTERS/George Frey/File Photo (Reuters) – Delaware on Friday became the latest state to file ... More »
LONDON (Reuters) – A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds ($27 million) from investors including GV, the venture capital arm of Google parent Alphabet Inc. Vacc... More »
SAN FRANCISCO (Reuters) – Global drugmakers are looking to a tiny biotech’s $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines. Spark Therapeutics Inc plans to launch its recently appr... More »
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, January 30, 2014. To match special report USA-FDA/CASES REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – The European Union approved Roche’s multiple sclerosis medici... More »
FILE PHOTO: A pharmacist holds prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.P. at a local pharmacy, in Provo, Utah, U.S. on April 25, 2017. REUTERS/George Frey/File Photo (Reuters) – A federal judge pushing for a quick settlement of l... More »
FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. REUTERS/Ina Fassbender/File Photo (Reuters) – A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury aw... More »
A tourist poses for a photo with Teva Pharmaceutical Industries employees protesting outside Jerusalem’s Old City December 24, 2017. REUTERS/Amir Cohen TEL AVIV (Reuters) – Israel’s largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Ph... More »
WASHINGTON (Reuters) – Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Fri... More »
FILE PHOTO — A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid/File Photo (Reuters) – A U.S. judge on Friday overturned a $150 million verdict against AbbVie In... More »
(Reuters) – Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company’s eye-pain drug Dextenza. Shares of the company were down 7.2 percent at $4.25 in after-marketing tr... More »
A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo (Reuters) – Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administr... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo (Reuters) – Swiss drugmaker Roche (ROG.S) will buy U.S. cancer drugmaker Ignyta Inc (RXDX.O) ... More »
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann ZURICH (Reuters) – The U.S. Food and Drug Administration has granted priority review for Novartis... More »
(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics. The deal would come as large phar... More »
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland, January 25, 2017. REUTERS/Arnd Wiegmann/File Photo (Reuters) – California’s top court on Thursday opened the door for consumers to sue Novartis AG and other ... More »
(Reuters) – La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure. The company said it plans to make Giapreza available for patients in the United States in March... More »
FILE PHOTO: A used container of the drug Narcan used against opioid overdoses lies on the ground in a park in the Kensington section of Philadelphia, Pennsylvania, U.S. October 26, 2017. REUTERS/Charles Mostoller CHICAGO (Reuters) – The opioid crisis is rippli... More »
Vials of MPC-150-IM, Mesoblast’s stem cell product, are seen in this undated handout photo received December 14, 2017. Mesoblast/Handout via REUTERS NEW YORK (Reuters) – The early hope that stem cell therapy would make the paralyzed walk, the blind see and cur... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Roche’s patent dispute with London-listed Shire over the Swiss drugmaker’s... More »
(Reuters) – Aclaris Therapeutics Inc’s drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug Administration, the company said on Friday. It is the only topical medicine for the condition to receive... More »
COPENHAGEN (Reuters) – Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts’ panel issued a positive recommendation on Friday. The once-wee... More »
(Reuters) – The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday. All ongoing studies of the drug, fitusiran, had been pla... More »
Anopheles minimus mosquitoes are pictured at a lab in the Public Health Ministry in Bangkok, Thailand, November 9, 2017. Picture taken November 9, 2017.REUTERS/Athit Perawongmetha BO RAI, Thailand (Reuters) – Once a smuggling stop for Cambodia’s Khmer Rouge gu... More »
The logo of German pharmaceuticals company Merck is seen in front of the company’s headquarters in Darmstadt, Germany, May 16, 2016. REUTERS/Kai Pfaffenbach FRANKFURT (Reuters) – Germany’s Merck KGaA (MRCG.DE) is reviving plans to bring an oral multiple sclero... More »
Marijuana plants are seen in an indoor marijuana plantation of a marijuana smokers club in the outskirts of Montevideo, Uruguay July 16, 2017. Picture taken July 16, 2017 REUTERS/Andres Stapff LONDON (Reuters) – An ingredient in cannabis called cannabidiol or ... More »
LOS ANGELES (Reuters) – Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. Shares of Merck have fallen 10... More »
(Reuters) – More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc’s experimental gene-modifying immunotherapy in a small, early stage study, according to... More »
(Reuters) – The trade group representing U.S. drugmakers on Friday said it has a filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices. The Pharmaceutical Research and Manufacturers of America (PhRMA), in a sta... More »
Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy dru... More »
(Reuters) – Drug developer Sage Therapeutics Inc’s shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial. Sage’s shares were up 73 percent at $159, on tr... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Adding Roche’s (ROG.S) immunotherapy Tecentriq to older drugs doubled the ... More »
Rodents have joined mosquitoes in the cross-hairs of scientists working on a next-generation genetic technology known as "gene drive" to control pests. More »
FILE PHOTO – U.S. Administrator of the Centers for Medicare and Medicaid Services (CMS) Seema Verma (C) is joined by Concerned Women for America CEO Penny Nance (L) as she talks to reporters about President Trump’s signing of House Resolution 43, which allows ... More »
(Reuters) – Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product. Shares... More »
FILE PHOTO: Genmab Chief Executive Jan van de Winkel poses for a photograph in London, Britain, October 13, 2016. REUTERS/Ben Hirschler/File Photo LONDON (Reuters) – Genmab (GEN.CO) was Europe’s second biggest biotech company, until its partner Johnson & Johns... More »
LONDON, (Reuters) – Doctors in France have found the first evidence that a drug normally used to treat lung, kidney or skin cancer may be able to eradicate HIV-infected cells in people with the AIDS virus. In a case described as potentially exciting by scienti... More »
CHICAGO (Reuters) – A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said. The test, known as F... More »
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo LONDON (Reuters) – Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new d... More »
People gather outside a health center as they wait to get treatment for malaria, in San Felix, Venezuela November 3, 2017. REUTERS/William Urdaneta CIUDAD GUAYANA, Venezuela (Reuters) – On a recent morning in Venezuela’s southern jungle state of Bolivar, Amand... More »
LONDON, Nov 23 (Reuters) – – An experimental therapy for people with schizophrenia that brings them face to face with a computer avatar representing the tormenting voices in their heads has proved promising in early stage trials. Scientists who conducted a ran... More »
LEVERKUSEN, Germany (Reuters) – Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces a threat to revenues in 2024 when the blockbuster heart drug Xarelto loses its patent. The firm’s p... More »
FILE PHOTO: FILE PHOTO: Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecen... More »
CAPE TOWN (Reuters) – Developing new front-line antiretroviral (ARV) drugs and using technology for early diagnosis are among key steps needed to sustain momentum in fighting HIV/Aids and ending the disease as a public health threat by 2030, UNAIDS said in a r... More »
A digital pill with an embedded sensor to track if patients are taking their medication. REUTERS/Proteus Digital Health (Reuters) – U.S. regulators have approved the first digital pill with an embedded sensor to track if patients are taking their medication pr... More »
The U.S. Food and Drug Administration said on Monday that it had approved Otsuka Pharmaceutical Co Ltd's Abilify MyCite, the first drug with a digital ingestion tracking system to be approved in the United States. More »
Tighter blood pressure guidelines from U.S. heart organizations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular problems. More »
President Donald Trump on Monday said he is nominating former pharmaceutical executive and industry lobbyist Alex Azar to serve as U.S. Health and Human Services secretary, saying Azar would push to lower the price of medicines. More »
The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said on Tuesday. More »
Restaurant chain Buffalo Wild Wings Inc (BWLD.O) has received a takeover bid valued at more than $2.3 billion from private equity firm Roark Capital Group, the Wall Street Journal reported on Monday, citing people familiar with the matter. More »
Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the drug. More »
The U.S. Drug Enforcement Administration said on Thursday that it would classify illicit versions of the synthetic opioid fentanyl at the same level as heroin, allowing criminal prosecution of anyone who possesses, distributes or manufactures illicit versions ... More »
Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary." More »
Johnson & Johnson's blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared with a placebo in a midstage clinical trial, according to data released on Saturday. More »
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim. More »
The proposed merger between U.S. pharmacy operator CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion bet that insurers can drive down high U.S. drug prices by cutting out the middleman. More »
Merck & Co (MRK.N) on Friday said quarterly sales of its Keytruda cancer immunotherapy exceeded $1 billion for the first time, but it withdrew an application for European use of the drug in lung cancer, raising questions about future sales. More »
U.S. pharmacy operator CVS Health Corp's (CVS.N) move to buy health insurer Aetna Inc (AET.N) could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said. More »
Eagle Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration tentatively approved its diluted version of Eli Lilly and Co's blockbuster cancer drug Alimta. More »
The billionaire founder of Insys Therapeutics Inc was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic. More »
Endo International Plc said two units filed a lawsuit on Thursday accusing the U.S. Food and Drug Administration of ignoring key components of a law passed after a deadly 2012 meningitis outbreak linked to a compounding pharmacy. More »
U.S. President Donald Trump declared the opioid crisis a public health emergency on Thursday, stopping short of a national emergency declaration he promised months ago that would have freed up more federal money. More »
U.S. Attorney General Jeff Sessions equated the opioid epidemic to a personal failing by many Americans who cannot "say no" to drugs on Thursday, and he said that marijuana could be serving as a gateway to the problem. More »
GlaxoSmithKline's gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price tag of almost 600,000 euros ($700,000). More »
GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year. More »
Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery. More »
A California judge on Friday threw out a $417 million verdict against Johnson & Johnson (JNJ.N) in a lawsuit by a woman who claimed she developed ovarian cancer after using its talc-based products like Johnson's Baby Powder for feminine hygiene. More »
Peru's conservative Congress passed a bill to legalize medical marijuana late on Thursday with a 68-5 vote in favor of allowing cannabis oil to be produced, imported and commercialized. More »
Airbus SE has agreed to buy a majority stake in Bombardier Inc's CSeries jetliner program, giving a powerful boost to the Canadian plane and train maker in its costly trade dispute with Boeing Co. More »
An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. More »
Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. More »
A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent. More »
Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent. More »
Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court. More »
Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. More »
The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. More »
